1900 related articles for article (PubMed ID: 19302902)
21. Impact of previous use of antibiotics on development of resistance to extended-spectrum cephalosporins in patients with enterobacter bacteremia.
Lee SO; Kim YS; Kim BN; Kim MN; Woo JH; Ryu J
Eur J Clin Microbiol Infect Dis; 2002 Aug; 21(8):577-81. PubMed ID: 12226687
[TBL] [Abstract][Full Text] [Related]
22. Early predictors for infection recurrence and death in patients with ventilator-associated pneumonia.
Combes A; Luyt CE; Fagon JY; Wolff M; Trouillet JL; Chastre J
Crit Care Med; 2007 Jan; 35(1):146-54. PubMed ID: 17080004
[TBL] [Abstract][Full Text] [Related]
23. Antibiotic therapy for gram-negative bacteremia.
Calandra T; Cometta A
Infect Dis Clin North Am; 1991 Dec; 5(4):817-34. PubMed ID: 1783770
[TBL] [Abstract][Full Text] [Related]
24. Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: an observational, multicenter study comparing monotherapy with combination antibiotic therapy.
Garnacho-Montero J; Sa-Borges M; Sole-Violan J; Barcenilla F; Escoresca-Ortega A; Ochoa M; Cayuela A; Rello J
Crit Care Med; 2007 Aug; 35(8):1888-95. PubMed ID: 17581492
[TBL] [Abstract][Full Text] [Related]
25. Combined aztreonam and gentamicin therapy for pseudomonal lower respiratory tract infections.
Andrews R; Fasoli R; Scoggins WG; Algozzine GJ; Spann RW; Sundaresh KV; Mathers JA; Babb R; Kuppinger M; Cooper B
Clin Ther; 1994; 16(2):236-52. PubMed ID: 8062319
[TBL] [Abstract][Full Text] [Related]
26. Citrobacter infections in a tertiary care hospital in Northern India.
Mohanty S; Singhal R; Sood S; Dhawan B; Kapil A; Das BK
J Infect; 2007 Jan; 54(1):58-64. PubMed ID: 16815552
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of cefepime versus ceftazidime in the treatment of adult pneumonia.
Lin JC; Yeh KM; Peng MY; Chang FY
J Microbiol Immunol Infect; 2001 Jun; 34(2):131-7. PubMed ID: 11456359
[TBL] [Abstract][Full Text] [Related]
28. Assessment of the clinical significance of production of extended-spectrum beta-lactamases (ESBL) by Enterobacteriaceae.
Henshke-Bar-Meir R; Yinnon AM; Rudensky B; Attias D; Schlesinger Y; Raveh D
Infection; 2006 Apr; 34(2):66-74. PubMed ID: 16703295
[TBL] [Abstract][Full Text] [Related]
29. Favourable outcomes in episodes of Pseudomonas bacteraemia when associated with tunnelled cuffed catheters (TCCs) in chronic haemodialysis patients.
Golestaneh L; Laut J; Rosenberg S; Zhang M; Mokrzycki MH
Nephrol Dial Transplant; 2006 May; 21(5):1328-33. PubMed ID: 16421157
[TBL] [Abstract][Full Text] [Related]
30. Fluoroquinolone-resistant Pseudomonas aeruginosa: risk factors for acquisition and impact on outcomes.
Hsu DI; Okamoto MP; Murthy R; Wong-Beringer A
J Antimicrob Chemother; 2005 Apr; 55(4):535-41. PubMed ID: 15728150
[TBL] [Abstract][Full Text] [Related]
31. Restriction of third-generation cephalosporin use decreases infection-related mortality.
Du B; Chen D; Liu D; Long Y; Shi Y; Wang H; Rui X; Cui N
Crit Care Med; 2003 Apr; 31(4):1088-93. PubMed ID: 12682477
[TBL] [Abstract][Full Text] [Related]
32. Risk factors and clinical outcomes of nosocomial multi-drug resistant Pseudomonas aeruginosa infections.
Cao B; Wang H; Sun H; Zhu Y; Chen M
J Hosp Infect; 2004 Jun; 57(2):112-8. PubMed ID: 15183240
[TBL] [Abstract][Full Text] [Related]
33. Clinical characteristics and risk factors for attributable mortality in Enterobacter cloacae bacteremia.
Lin YC; Chen TL; Ju HL; Chen HS; Wang FD; Yu KW; Liu CY
J Microbiol Immunol Infect; 2006 Feb; 39(1):67-72. PubMed ID: 16440126
[TBL] [Abstract][Full Text] [Related]
34. High-risk febrile neutropenia in Auckland 2003-2004: the influence of the microbiology laboratory on patient treatment and the use of pathogen-specific therapy.
Ritchie S; Palmer S; Ellis-Pegler R
Intern Med J; 2007 Jan; 37(1):26-31. PubMed ID: 17199841
[TBL] [Abstract][Full Text] [Related]
35. Hospital-acquired pneumonia in critically ill patients: factors associated with episodes due to imipenem-resistant organisms.
Leroy O; d'Escrivan T; Devos P; Dubreuil L; Kipnis E; Georges H
Infection; 2005 Jun; 33(3):129-35. PubMed ID: 15940413
[TBL] [Abstract][Full Text] [Related]
36. Epidemiology and outcome of Pseudomonas aeruginosa bacteremia, with special emphasis on the influence of antibiotic treatment. Analysis of 189 episodes.
Vidal F; Mensa J; Almela M; Martínez JA; Marco F; Casals C; Gatell JM; Soriano E; Jimenez de Anta MT
Arch Intern Med; 1996 Oct; 156(18):2121-6. PubMed ID: 8862105
[TBL] [Abstract][Full Text] [Related]
37. Five years of nosocomial Gram-negative bacteremia in a general intensive care unit: epidemiology, antimicrobial susceptibility patterns, and outcomes.
Sligl W; Taylor G; Brindley PG
Int J Infect Dis; 2006 Jul; 10(4):320-5. PubMed ID: 16460982
[TBL] [Abstract][Full Text] [Related]
38. Oral ciprofloxacin in the treatment of elderly patients with complicated urinary tract infections due to trimethoprim/sulfamethoxazole-resistant bacteria.
Preheim LC; Cuevas TA; Roccaforte JS; Mellencamp MA; Bittner MJ
Am J Med; 1987 Apr; 82(4A):295-300. PubMed ID: 3555051
[TBL] [Abstract][Full Text] [Related]
39. Optimising antibiotic dosing regimens based on pharmacodynamic target attainment against Pseudomonas aeruginosa collected in Hungarian hospitals.
Ludwig E; Konkoly-Thege M; Kuti JL; Nicolau DP
Int J Antimicrob Agents; 2006 Nov; 28(5):433-8. PubMed ID: 17046212
[TBL] [Abstract][Full Text] [Related]
40. [Nosocomial bacteremia caused by Enterobacter spp.: epidemiology and prognostic factors].
Peña C; Pujol M; Pallarés R; Cisnal M; Ariza J; Gudiol F
Enferm Infecc Microbiol Clin; 1993 Oct; 11(8):424-8. PubMed ID: 8260514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
